pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,162 catalysts · 4,876 phase readout · 2,366 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 28 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: earnings×clear all
type
  • phase readout4,876
  • 8k filing2,366
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03301506: Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

    Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Primary Biliary Cirrhosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04619004: HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

    Sponsor: Daiichi Sankyo. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06344884: Early Patient Removal of Urinary Catheters After Urogynecologic Surgery

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Urinary Retention Postoperative, Postoperative Urinary Tract Infection, Catheter Site Pain

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03322033: Feasibility of Endovascular Repair of Ascending Aortic Pathologies

    Sponsor: Baylor Research Institute. Phase: NA. Conditions: Dissection of Thoracic Aorta

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06977633: Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes

    Sponsor: Mahla Poudineh. Phase: NA. Conditions: Type 1 Diabetes (T1D)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07564752: The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06087952: Leiden Thrombosis Recurrence Risk Prevention

    Sponsor: Leiden University Medical Center. Phase: NA. Conditions: Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism, Deep Vein Thrombosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04388852: DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Prostate Carcinoma, Metastatic Urothelial Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01747447: VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)

    Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Bone Density, Body Composition, Bone Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07317947: Lateral Crural Steal With Columellar Strut Graft in Primary Open Rhinoplasty

    Sponsor: Kafrelsheikh University. Phase: NA. Conditions: Rhinoplasty, Nasal Surgery, Aesthetic Outcomes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07288047: Virtual Reality as a Method for Pain and Anxiety Control During First Trimester Procedural Abortion

    Sponsor: Study Investigator. Phase: NA. Conditions: Abortion, First Trimester, Pain Management, Pain After Surgery, Satisfaction, Satisfaction With Care, Anxiety After Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06566547: GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma

    Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04927949: Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not

    Sponsor: University Hospital, Caen. Phase: PHASE4. Conditions: ST-elevation Myocardial Infarction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07540338: A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

    Sponsor: Alzamend Neuro, Inc.. Phase: PHASE1. Conditions: Bipolar I Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07534358: Intensive Case Management Between VA and Community Care for Suicide Prevention

    Sponsor: VA Eastern Colorado Health Care System. Phase: NA. Conditions: Suicidal Ideation, Mental Health Issue, Social Determinants of Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07621458: Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism

    Sponsor: Seoul National University Hospital. Phase: . Conditions: Primary Aldosteronism

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06884748: Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

    Sponsor: Medical College of Wisconsin. Phase: EARLY_PHASE1. Conditions: Clostridioides Difficile Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07610148: A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants

    Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451548: RCT on Running Water Sound During Urodynamic

    Sponsor: Princess Margaret Hospital, Hong Kong. Phase: NA. Conditions: Lower Urinary Tract Symptoms (LUTS)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06547255: Exparel Versus Bupivacaine in Post-operative Pain Control

    Sponsor: Case Western Reserve University. Phase: PHASE4. Conditions: Liposomal Bupivacaine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05849155: Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

    Sponsor: St. Jude Children's Research Hospital. Phase: . Conditions: Genetic Predisposition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07586826: Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

    Sponsor: Peking University People's Hospital. Phase: PHASE2. Conditions: Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers, Ovarian Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cervical Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07572526: tDCS: Sleep to Mood in Depression (S2M-D)

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Major Depressive Disorder, MDD, Depression, Major Depressive Episode

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04358926: Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)

    Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: COVID-19, Desaturation of Blood

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06724926: Concurrent Azeliragon With Craniospinal Irradiation

    Sponsor: NYU Langone Health. Phase: PHASE1. Conditions: Solid Tumor, High-grade Glioma, Leptomeningeal Metastasis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06197178: A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

    Sponsor: Peking University. Phase: PHASE1. Conditions: Advanced Gastrointestinal Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07623278: Bacterial Profile Changes During Different Sodium Hypochlorite Irrigation Regimens and Calcium Hydroxide Medicament in Root Canal Treatment

    Sponsor: Hasanuddin University. Phase: NA. Conditions: Chronic Apical Abscess, Root Canal Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05799755: Myositis Interstitial Lung Disease Nintedanib Trial

    Sponsor: Rohit Aggarwal, MD. Phase: PHASE4. Conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06120855: Study on Regulated Cannabis Sales in Pharmacies

    Sponsor: University of Bern. Phase: NA. Conditions: Marijuana Smoking, Cannabis, Cannabis Use

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04276155: Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

    Sponsor: Centre Hospitalier de PAU. Phase: PHASE4. Conditions: Atrial Fibrillation, Myocardial Infarction

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT05535426: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04362826: Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer

    Sponsor: Case Comprehensive Cancer Center. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07537985: Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment

    Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Hepatocellulcar Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442643: Epinephrine-Added Irrigation Versus Intravenous Tranexamic Acid in Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial

    Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Rotator Cuff Tear

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02696343: Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants

    Sponsor: University of Nebraska Lincoln. Phase: NA. Conditions: Infant, Extremely Low Birth Weight, Feeding Behavior

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07402915: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07181915: Changing Outcomes Through Achievement Emails in COPD Using Routine Healthcare Audits

    Sponsor: University of Leeds. Phase: NA. Conditions: COPD (Chronic Obstructive Pulmonary Disease)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07122011: Neural Contributions to Exercise-Induced Hypoalgesia With Blood Flow Restriction

    Sponsor: University of Gran Rosario. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03372811: Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)

    Sponsor: Psoriasis Research Institute of Guangzhou. Phase: PHASE2. Conditions: Psoriasis Vulgaris, Topical Administration

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05490771: Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07596771: Effects of AI-Generated Animated Videos on Dental Anxiety in Children

    Sponsor: Alanya Alaaddin Keykubat University. Phase: NA. Conditions: Pediatric Dental Anxiety

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07426744: Antipyretic Therapy With and Without Cold Sponging

    Sponsor: Muhammad Aamir Latif. Phase: NA. Conditions: Fever

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03915444: Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

    Sponsor: HonorHealth Research Institute. Phase: PHASE2. Conditions: Pancreatic Ductal Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06259734: Transfusion Camp for Medical Students in Rwanda

    Sponsor: University of British Columbia. Phase: NA. Conditions: Global Health, Medical Education

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07518264: Efficacy and Underlying Mechanisms of Group-Based Natural Psychotherapy for Anxiety Disorder

    Sponsor: Beijing HuiLongGuan Hospital. Phase: NA. Conditions: Obsessive - Compulsive Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06580509: TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: EARLY_PHASE1. Conditions: Hemorrhage, Surgical, Tonsillar Bleeding

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07503509: Physiological Study of High PEEP in Noninvasive Ventilation

    Sponsor: Chongqing Medical University. Phase: NA. Conditions: Respiratory Failure With Hypoxia

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT04222309: Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

    Sponsor: Northwell Health. Phase: PHASE1. Conditions: Glioma, Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain, GBM, Brain Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05752799: Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids

    Sponsor: G.Gennimatas General Hospital. Phase: NA. Conditions: Opioid Use, Unspecified, Bariatric Surgery Candidate

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05883332: A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters

    Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Lower Urinary Tract Symptoms

    full page →ctgov ↗
    ← prev
    page 51 of 104
    next →